Phibro Animal Health Co. (NASDAQ:PAHC) Shares Purchased by Zacks Investment Management

Zacks Investment Management raised its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 329.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,222 shares of the company’s stock after purchasing an additional 40,064 shares during the quarter. Zacks Investment Management owned about 0.13% of Phibro Animal Health worth $1,097,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of PAHC. Vanguard Group Inc. boosted its position in Phibro Animal Health by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock valued at $31,809,000 after buying an additional 20,604 shares during the last quarter. American Century Companies Inc. grew its stake in Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after purchasing an additional 96,787 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Phibro Animal Health by 1.9% during the 4th quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after purchasing an additional 10,600 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Phibro Animal Health by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock valued at $10,838,000 after purchasing an additional 8,510 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of Phibro Animal Health by 35.6% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 322,090 shares of the company’s stock valued at $6,764,000 after buying an additional 84,599 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Tuesday, March 25th. Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Finally, Morgan Stanley set a $20.00 price target on Phibro Animal Health in a research note on Tuesday. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $19.75.

Phibro Animal Health Trading Up 2.7 %

Phibro Animal Health stock opened at $17.29 on Friday. Phibro Animal Health Co. has a 1 year low of $12.30 and a 1 year high of $26.55. The firm’s 50-day moving average is $21.46 and its 200-day moving average is $22.28. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a market cap of $700.30 million, a P/E ratio of 36.02, a PEG ratio of 0.45 and a beta of 0.63.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.78%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.